STC heads into its October 21 earnings report trading below the Street's consensus target, with analyst sentiment cooling just as short sellers trim positions and options traders lean increasingly bullish.
The most telling move came from Keefe, Bruyette & Woods at the end of July. Analyst Bose George — who had been one of the stock's more consistent bulls, lifting his target twice in early 2026 — flipped to Market Perform and cut his target to $71, right around where the stock is currently trading at $68.61. That downgrade matters because KBW is the bellwether name in specialty financial coverage, and George's reversal signals that Q2 results — which pushed STC down more than 8% the day they were reported in late July — raised enough margin concerns to shake a formerly constructive view. The broader analyst picture remains split: Benchmark initiated at Buy with an $87 target on July 21, and Stephens holds Overweight at $88. The mean target sits at $82.25, roughly 20% above the current price, but that gap looks increasingly theoretical given KBW's retreat. The bear case centres on operating margin compression — projected at just 11% for 2025 — and the fade in commercial real estate momentum after an exceptional first half. The bull case rests on multi-year fee-per-file growth and a revenue ramp into 2027.
Short positioning tells a more relaxed story, and that contrast is worth noting. SI has fallen roughly 6% on the week to 3.8% of the free float — a meaningful reduction, but not at a level that would characterise shorts as crowded or aggressive in the first place. Borrowing cost has edged up about 24% on the month to 0.49%, though in absolute terms that remains firmly in "easy borrow" territory. Availability is extraordinarily loose at over 3,700% — meaning there are roughly 37 shares available to borrow for every one already lent out. Nothing in the lending market suggests short sellers are under pressure or building conviction. The ORTEX short score has drifted lower through August, moving from 40.4 to 38.3, pointing to a gradual easing of bearish positioning rather than any building of pressure.
Options traders are the most bullish voice in the room right now. The put/call ratio has dropped to 0.14, well below its 20-day average of 0.18, with a z-score of -1.3 — the most call-skewed the options market has been in recent weeks. That reading sits near the low end of the past year's range, though well above the 52-week floor of 0.02. The direction of travel is clear: as the KBW downgrade and post-earnings selling have dragged the stock from mid-$70s to the high $60s, options activity has become progressively more call-heavy, not less. Whether that reflects genuine conviction or simply the mechanical effect of a thinner options market, the put/call ratio is not flagging defensiveness.
On valuation, STC trades at roughly 10.5x trailing earnings and 1.2x book — undemanding multiples for a title insurer, though the EV/EBITDA of 7.6x has slipped about 0.1x over the past month as the stock has softened. The factor score picture is mixed: a dividend score in the 97th percentile reflects the stock's income credentials, while the EPS surprise rank of just 29 flags a history of underwhelming on earnings delivery — consistent with Q2's negative reaction. EPS momentum over 90 days ranks in the bottom decile at 10, though the 30-day reading has recovered to 66, hinting that near-term estimate revisions have stabilised after post-earnings cuts. Among peers, FNF and ITIC both fell on the week — down 2.8% and 3.3% respectively — while FAF managed a slim 0.4% gain, suggesting the sector-wide tone is cautious rather than specifically bearish on STC.
The October 21 report is the next hard catalyst. Given that the stock has fallen on each of the last two earnings days — by 3.3% and 8.4% — the question is whether the KBW downgrade and modest short-covering represent the market finding a floor ahead of that print, or simply a pause before the next test of management's margin recovery story.
See the live data behind this article on ORTEX.
Open STC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
